We are facing various crises of global pandemic including COVID-19, Russia’s war, geopolitical changes, economic crises, and regional security threat. Preconditions have changed drastically, and we are at a critical juncture to fundamentally reconsider policies and framework to deal with such crises. We need to address appropriate resources and policies, through building resilient global communities and knowledge-based resource hubs. GHIPP is strengthening global partnership by building “Japan’s challenges” discussion platforms and sharing knowledge, lessons learned, and vision by creating new regional communities for resilience.
23rd Special Dialogue (4/5) “Japan’s challenges and policy response” with Prof. Kent E. Calder
22nd Special Dialogue “Japan’s Place in the Dollar-based Global Financial Order: History and Outlook”
Prof. R. Taggart Murphy is Emeritus Professor of International Political Economy at the University of Tsukuba. He was a founder of the University’s MBA Program in International Business and served as its Program Chair from 2011-2014. Previously, he had taught at the University’s College of International Studies and Graduate Program in International Political Economy. Before launching his academic career, Murphy was an investment banker with twelve years’ experience in the Japanese financial markets. He was a Non-Resident Senior Visiting Fellow at the Brookings Institution and is the author of “The Weight of the Yen” (Norton: 1996), “Japan’s Policy Trap” (Brookings), co-authored with Akio Mikuni, and “Japan and the Shackles of the Past” (Oxford, 2014), which was heralded by The Economist as “an insightful analysis of what ails Japan.” Murphy’s articles have appeared in The New Republic, The National Interest, The Harvard Business Review, Fortune, The London Review of Books, and The New Left Review as well as the op-ed page of the The New York Times.
21st Special Dialogue “Japan’s challenge: Changing threats and policies toward China”
Dr. Sheila A. Smith is is John E. Merow senior fellow for Asia-Pacific studies at the Council on Foreign Relations (CFR). An expert on Japanese politics and foreign policy, she is the author of Japan Rearmed: The Politics of Military Power, Intimate Rivals: Japanese Domestic Politics and a Rising China (released in Japanese as 日中 親愛なる宿敵: 変容する日本政治と対中政策), and Japan’s New Politics and the U.S.-Japan Alliance. She is also the author of the CFR interactive guide Constitutional Change in Japan. Dr. Smith is a regular contributor to the CFR blog Asia Unbound and a frequent contributor to major media outlets in the United States and Asia.
(Commentator) Dr. Narushige Michishita is Vice President and professor at GRIPS. Previously, he served as senior research fellow at the National Institute for Defense Studies (NIDS), Ministry of Defense and assistant counsellor at the Cabinet Secretariat for Security and Crisis Management of the Government of Japan. A specialist in Japanese security and foreign policy as well as security issues on the Korean Peninsula, his works include North Korea’s Military-Diplomatic Campaigns, 1966-2008 (Routledge, 2009). He is fluent in Japanese and Korean.
20th Special Dialogue “Pandemic, Ukraine, and Taiwan: challenges for Japan and the US”
Dr. Richard J Samuels is Ford International Professor of Political Science and director of the Center for International Studies at the MIT. He has been head of the MIT Political Science Department, Vice-Chair of the Committee on Japan of the National Research Council, and chair of the Japan-US Friendship Commission. He has also been elected to the American Academy of Arts & Sciences and was awarded an Imperial decoration, the Order of the Rising Sun, Gold and Silver Star by the Emperor of Japan and the Japanese Prime Minister.
Mr. Samuel Leiter is a PhD student specializing in Security Studies and International Relations. He is primarily interested in proliferation, preventive war, East Asian security, and alliance politics. He graduated with general and departmental honors from the University of Chicago with a BA in Political Science and previously worked at the Civic Consulting Alliance.
Dr. Eric Heginbotham is a principal research scientist at MIT’s Center for International Studies and a specialist in Asian security issues. Before joining MIT, he was a senior political scientist at the RAND Corporation, where he led research projects on China, Japan, and regional security issues and regularly briefed senior military, intelligence, and political leaders. After graduating from Swarthmore College, Heginbotham earned his PhD in political science from MIT. He is fluent in Chinese and Japanese and was a captain in the US Army Reserve.
19th Special Dialogue “Pandemic, Ukraine, and Taiwan: challenges for Japan and the US”
Dr. Zack Cooper, senior fellow at American Enterprise Institute, specializes US strategy in Asia. He also teaches at Princeton University, codirects the Alliance for Securing Democracy, and cohosts the “Net Assessment” podcast. He also served as assistant to the deputy national security adviser for combating terrorism at the National Security Council and as a special assistant to the principal deputy under secretary of defense for policy at the Department of Defense.
18th Special Dialogue “Safety and Security of nuclear power plants: Challenges for Ukraine and the world”
Dr. Sergiy Korsunsky, Ambassador Extraordinary and Plenipotentiary of Ukraine to Japan: previously director of the Diplomatic Academy of Ukraine, Ambassador to the Republic of Turkey, holds a Doctor of Science Degree in Applied Mathematics. Author of more than 320 academic papers and books including “Energy Diplomacy” (Kyiv, 2008), “Foreign Policy in Times of Transformations” (Kharkiv, 2020).
17th Special Dialogue “Global pandemic, Russia’s war, and China’s rise: Japan’s challenges”
Mr. Bill Emmott is a writer best known for his time as editor in chief of The Economist in 1993-2006 but also for his many books on Japan, which began with the bestselling “The Sun Also Sets: Why Japan will not be Number One” (1989). He is now chair of the Japan Society of the UK, of the International Institute for Strategic Studies, and of Trinity College Dublin’s Long Room Hub for Arts & Humanities, is co-director of the Global Commission for Post-Pandemic Policy and is a member of the Comitato Scientifico of the Centro Einaudi in Turin.
16th Special Dialogue “COVID-19 and Beyond: Japan’s Challenge and Contributions to Global Health”
Hon. Keizo Takemi, an LDP member of the House of Councillors of the Japanese parliament, chair of caucus on Stop TB, engaged in Commission on Information and Accountability for Women’s and Children’s Health, Global Health Workforce Alliance, and WHO expert working group on R&D Financing. He is a senior fellow with the Japan Center for International Exchange and was a research fellow at the Harvard School of Public Health (2007-2009).
15th Special Dialogue “COVID-19 and Beyond: Japan’s Challenge and Building Sustainable and Resilient Health System”
Dr. Kenji Shibuya is Director of the Soma COVID Vaccination Medical Center in the city of Soma, Fukushima. Previously Professor and Director of the Institute for Population Health at King’s College London. Professor and Chair of the Department of Global Health Policy at the University of Tokyo and Coordinator at the World Health Organization (WHO). Dr. Shibuya has been Senior Advisor to the WHO director-general and a member of the Scientific Advisory Committee of the Coalition for Epidemic Preparedness Innovations (CEPI), a pandemic vaccine fund, investing in COVID-19 vaccines.
14th Special Dialogue “COVID-19 and Beyond: Changing the Future through Health Innovations”
Prof. Vivek Wadhwa is a distinguished Fellow, Harvard Law School’s Labor and Worklife program, and the author of five best-selling books: From Incremental to Exponential; Your Happiness Was Hacked; The Driver in the Driverless Car; Innovating Women; and The Immigrant Exodus. He has been a globally syndicated columnist for The Washington Post and held appointments at Carnegie Mellon University, Duke University, Stanford Law School, UC Berkeley, Emory University, and Singularity University. He was also named one of the world’s “Top 100 Global Thinkers” by Foreign Policy magazine in that year; in June 2013, he was on TIME magazine’s list of “Tech 40”, one of forty of the most influential minds in tech. Vivek is based in Silicon Valley and researches, speaks, and writes about advancing technologies that are transforming our world.
13th Special Dialogue “COVID-19 and Beyond: US-China Geostrategic Competition on Health and Environment Issues”
Dr. Paul Linehan, CEO of Secure Knowledge Consulting, LLC, has 37 years of professional experience in federal government service and devoted to managing a range of Indo-Pacific business, defense, intelligence and national security affairs. In his final assignment in the Office of the Under Secretary of Defense for Policy, he served as the Director, Indo-Pacific for the National Disclosure Policy Committee and U.S. Designated Security Authority as U.S. Government lead expert for international security agreements, security certification of defense programs, industrial security, and national disclosure policy for the Indo-Pacific region. He holds master’s degrees in international affairs and China studies from The Johns Hopkins University School of Advanced International Studies and in national security studies from the National War College, National Defense University. He received his doctorate from Georgetown University. author of the book, “The Culture of Leadership in Contemporary China – Conflict, Values, and Perspectives for a New Generation”.
12th Special Dialogue “COVID-19 and Beyond: The East Asian Covid-19 Paradox”
Dr. Yves Tiberghien (Ph.D. Stanford University, 2002; Harvard Academy Scholar 2006; Fulbright Scholar 1996) is a Professor of Political Science and Konwakai Chair in Japanese Research at the University of British Columbia (UBC) in Vancouver, Canada. He is also Director Emeritus of the Institute of Asian Research, and Director of the Center for Japanese Research. Yves is Distinguished Fellow at the Asia-Pacific Foundation of Canada and a Senior Fellow at the University of Alberta’s China Institute. He is an International Steering Committee Member at Pacific Trade and Development Conference (PAFTAD). In November 2017, he was made a Chevalier de l’ordre national du mérite by the French President. He is a visiting Professor at Tokyo University’ Graduate School of Public Policy. He recently published The East Asian Covid-19 Paradox. August 2021. Elements in Politics and Society in East Asia, Cambridge: Cambridge University Press DOI: https://doi.org/10.1017/ 9781108973533
11th Special Dialogue “COVID-19 and Beyond: 〜パンデミック敗戦どう生かす〜”
大林 尚（Tsukasa Obayashi) 日本経済新聞 編集委員兼上級論説委員：1984年日本経済新聞社入社。千葉支局などを経て90年から東京本社経済部で通産省、日銀、経済企画庁、厚生省などの記者クラブに所属し、政策立案の現場を担当する。99年経済部次長。2002年編集委員、05年から論説委員を兼務し社会保障・消費税・財政改革、規制改革、独占禁止法を中心に社説とコラムを執筆。14年欧州総局編集委員、16年欧州総局長としてロンドンに駐在し、EU各国の社会保障・税制の現場やBrexitを決めた英国民投票を取材。17年東京本社に帰任、現在にいたる。慶應義塾大学総合政策学部特別招聘教授。Tsukasa Ohbayashi joined Nikkei Inc in 1984. Ohbayashi served as a deputy editor of Economic News Department, and then as senior staff writer and leader writer, writing editorials and columns on economic policies, such as taxation, finance, social security, and regulatory reforms.
10th Special Dialogue “COVID-19 and Beyond: Pfizer’s Global Trade Policy”
Elissa Alben, Esq. leads Pfizer’s Global Trade Policy team and is responsible for overseeing the development and execution of trade policy across all major markets in which Pfizer operates. Prior to joining Pfizer, Elissa served as senior trade counsel for Senate Finance Committee Democrats, responsible for Asia-Pacific trade negotiations, environment, labor, and investment matters, as well as negotiating and securing Congressional passage of trade promotion authority. Before joining the Finance Committee, Elissa spent nearly eight years in the Office of the United States Trade Representative, where she served as Deputy Assistant USTR for Enforcement and Monitoring and chief lawyer for U.S. trade agreements, including the U.S.-Korea Free Trade Agreement, and represented the United States in disputes before the World Trade Organization. Prior to her government service, Elissa practiced international trade law at Steptoe & Johnson LLP in Washington, DC. Elissa received her undergraduate degree from Harvard University, concentrating in East Asian Studies, and her law degree from Columbia Law School.
9th Special Dialogue “COVID-19 and Beyond: Kenyan Experience and Effort to contain COVID-19″
Professor Miriam K. Were is a Medical Doctor (University of Nairobi), and holds Masters and Doctor of Public Health degrees from Johns Hopkins University in USA. She holds Batchelor’s degree in Natural Science and qualified to teach Secondary school level Biology, Chemistry and Physical Education which she did for two years before Medical School. She worked in the United Nations agencies of UNICEF, World Health Organisation and the United Nations Population Fund. She is the former Chancellor of Moi University, a Member of Champions for AIDS-Free Generation, Kenya’s Goodwill Ambassador for Community Health, Co-Founder of UZIMA Foundation and serves on various boards. Among the honours she has received are Hideyo Noguchi Africa Prize by Japan; Queen Elizabeth II Gold Medal for Public Health; George G. Tolbert Award of the National Council of International Health, USA; Knight of the French National Honours for work in Mother and Child Health
8th Special Dialogue “COVID-19 and Beyond: Harnessing Human Immunity as the Next Frontier of Science”
Mr. Theodore (Ted) Schenkelberg, Co-founder and COO of the Human Vaccines Project (HVP) has more than 20 years of experience advancing biomedical and global health priorities across the nonprofit and for-profit sectors. Previously, Schenkelberg worked as a strategic consultant in the global health and biotech space, including work for a leading Indian health system and national initiatives on reproductive health and antibiotic resistance. He served for more than seven years as a Director at the International AIDS Vaccine Initiative (IAVI) where he played a key role in building a $50 million global vaccine design program. Schenkelberg brings strong private sector experience having worked as a licensed health and technology analyst at Carnegie Capital, an investment firm with more than $1 billion under management and administration.
7th Special Dialogue “COVID-19 and Beyond: Taiwan experience and effort to contain COVID-19”
Dr. Brian Bih-Jeng Chang, Director of Brian’s Family Doctor Clinic, New Taipei City, is an Honorary Secretary of WONCA, APR; Director of Brian’s Family Doctor Clinic, New Taipei City. He is Deputy secretary general of Taiwan Medical Association, WONCA APR Liaison Person of Taiwan Association of Family Medicine, Deputy secretary general of Taiwan Association of Family Medicine, and Adjunct attending physician of Department of Family Medicine, NTU hospital.
6th Special Dialogue ”COVID-19 and Beyond: Presidents versus Pandemicide”
Ms. Laurie Garrett, wrote her first bestselling book, THE COMING PLAGUE: Newly Emerging Diseases in a World Out of Balance, while splitting her time between the Harvard School of Public Health and the New York newspaper, Newsday. In the 1992-93 academic years Garrett was a Fellow at Harvard, where she worked closely with the emerging diseases group, a collection of faculty concerned about the surge in epidemics of previously unknown or rare viruses and bacteria. The book was published in hardcopy by Farrar, Straus, and Giroux in 1994, and spent 19 weeks on the New York Times bestseller list.
5th Special Dialogue “COVID-19 and Beyond: Australian experience and effort to contain COVID-19”
Dr. Sanjaya Senanayake is an Infectious Disease Physician in Canberra and an Associate Professor of Medicine at the Australian National University (ANU) Medical School. He has an interest in epidemiology and infections of public health importance and is a regulator commentator in the media on a range of public health issues including COVID-19. Dr Senanayake completed a Bachelor of Medical Science and Bachelor of Medicine and Surgery at the University of New South Wales, and Master of Applied Epidemiology from the ANU.
4th Special Dialogue “Global solidarity to end COVID-19 pandemic: Progress and challenges”
Dr. Osamu Kunii (M.D., M.P.H., Ph.D.) serves Head of Strategy, Investment and Impact Division of The Global Fund to fight AIDS, Tuberculosis and Malaria, managing 5 departments, namely Strategic Information; Technical Advice and Partnership; Technical Evaluation Reference Group Secretariat; Community, Rights and Gender; Access to Funding. He has worked more than 25 years of experience in global health, especially maternal and child health, infectious diseases control, health systems, health policy and diplomacy. He also served as Deputy Director of Aid Planning Division in the Japan Ministry of Foreign Affairs; Professor of Global Health at Nagasaki University, Research Institute of Tropical Medicine; Senior Advisor at UNICEF headquarters, Chief of Health and Child Survival Program in UNICEF Myanmar and Somalia Office.
3rd Dialogue “COVID-19 and Beyond: Lessons achieved under Pandemic Favipiravir deployment”
Koichi Yamada (Corporate Vice President, Anti-Infectives Business Unit Div. FUJIFILM Toyama Chemical Co, LTD.) underwent his undergraduate studies at Kyoto University, then, completed his MBA at Indiana University in the U.S. He first joined FUJIFILM Corporation, where his main responsibility was in overseas marketing. Since 2012, he has been involved into the development of an anti-influenza drug candidate with the U.S. Department of Defense funding, and took part in conducting clinical studies of favipiravir in the U.S. Upon the outbreak of the Ebola fever in East Africa in 2014, after several compassionate use cases, he conducted a clinical study on Ebola patients in Guinea in corporation with the French medical team. He has been working on the administration of the above drug to COVID-19 patients, since this spring.
Richard H. Kaszynski is Co-founder & Director at Stanford University School of Medicine, Stanford Solutions and Executive Director at Koto Medical Tower Tokyo Japan. He has co-established various favipiravir projects including the Favipiravir Ambulatory Treatment Evaluation for Covid-19 (FATE) Trial and A Phase 2 Randomized, Double Blinded, Placebo Controlled Study of Oral Favipiravir Compared to Standard Supportive Care in Subjects with Mild or Asymptomatic COVID-19. He serves as a Senior Medical advisor at the Embassy of the Democratic Republic of Congo, Tokyo, Japan. Previously worked as a medical doctor at Emergency Care and Disaster Medicine Center of Tokyo Metropolitan Hospital (Hiroo), a Fellow at Harvard Medical School, Massachusetts General Hospital Department of Anesthesia, Critical Care and Pain Medicine. He earned M.D. from Kobe University and Ph.D. from Kyoto University.
2nd Special Dialogue “COVID-19 and Beyond: What did we learn from Japanese experience?”
Yasuharu Tokuda, MD, MPH, PhD, FACP. Director and Project Leader, Muribushi Project for Teaching Hospitals, Okinawa. MPH alumni of Harvard School of Public Health. Current Affiliated Academic and Professional Appointments include Fellow of Health and Global Policy Institute, International Consultant of Taiwan Association of Hospital Medicine, Adjunct Professor of Tsukuba University, Ryukyu University, St. Marianna University, Dokkyo Medical University. Editor-in-Chief, Journal of General and Family Medicine (JGFM). Editorial Board Member, Korean Journal of Family Medicine. Recent article includes “COVID‐19 outbreak on the Diamond Princess Cruise Ship in February 2020“.
Jeff Kingston is Director of Asian Studies at Temple University Japan. Most recently he edited a 30-essay collection on the pandemic in Asia for The Asia Pacific Journal Japan Focus. His recent monographs include The Politics of Religion, Nationalism and Identity (2019) and Japan (2019), and he edited Critical Issues in Contemporary Japan (2019 and Press Freedom in Contemporary Japan (2017)) and co-edited Press Freedom in Contemporary Asia (2020) and Japan’s Foreign Relations with Asia (2018). He also wrote Nationalism in Asia: A History Since 1945 (2016) and edited Nationalisms in Asia Reconsidered (2015). His current research focuses on transitional justice and the politics of memory.
1st Special Dialogue” COVID-19 and Beyond: Post US presidential election and potential areas for US-Japan collaborations”
Dr. J. Stephen Morrison is a Senior Vice President at the CSIS, where he has directed the Global Health Policy Center since he founded it in September 2008. He directed the CSIS Africa Program (2000-2008), while also launching the CSIS Task Force on HIV/AIDS (2001-2007), co-chaired by Senators John Kerry and Bill Frist. During the Clinton administration, he served on the Policy Planning Staff, under Secretaries Christopher and Albright, and prior to that, conceptualized and founded USAID’s Office of Transition Initiatives. He served in the U.S. Embassy in Addis Ababa 1992-1993, directing its transitional work promoting democracy and good governance. In recent years at CSIS, Steve has directed several high-level commissions, most notably the CSIS Commission on Strengthening America’s Health Security (2018-present), and the CSIS Task Force on Women’s and Family Health (2015-2017.) He is the author of diverse analytic reports and commentaries, a frequent voice on global health, U.S. foreign policy, and international security, across a range of media. Steve received his PhD in political science at the University of Wisconsin-Madison. He is a graduate, magna cum laude, of Yale College.
Leave a Reply